Secukinumab: A life-changing treatment for Netherton syndrome?

[1]  Zhenlu Li,et al.  Successful treatment of Netherton syndrome with dupilumab: A case report and review of the literature , 2021, The Journal of dermatology.

[2]  R. Tomb,et al.  Le sécukinumab, une thérapie efficace du syndrome de Netherton , 2021, Annales de Dermatologie et de Vénéréologie - FMC.

[3]  O. Schilling,et al.  Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses. , 2021, The Journal of allergy and clinical immunology.

[4]  M. Herz-Ruelas,et al.  Netherton Syndrome: Case Report and Review of the Literature , 2021, Skin Appendage Disorders.

[5]  M. Akiyama,et al.  Successful dupilumab treatment for ichthyotic and atopic features of Netherton syndrome. , 2021, Journal of dermatological science.

[6]  T. Ergun,et al.  Netherton syndrome: Temporary response to dupilumab , 2020, Pediatric dermatology.

[7]  S. Ständer,et al.  Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  A. Hovnanian,et al.  Duality of Netherton syndrome manifestations and response to ixekizumab. , 2020, Journal of the American Academy of Dermatology.

[9]  J. Thyssen,et al.  Successful dupilumab treatment of an adult with Netherton syndrome. , 2020, Clinical and experimental dermatology.

[10]  A. Hovnanian,et al.  Secukinumab Therapy for Netherton Syndrome. , 2020, JAMA dermatology.

[11]  Sarah Blanchard,et al.  Successful use of secukinumab in Netherton syndrome , 2020, JAAD case reports.

[12]  D. Cohen,et al.  Treatment of Netherton Syndrome With Dupilumab. , 2020, JAMA dermatology.

[13]  B. Volc-Platzer,et al.  Successful treatment of Netherton syndrome with ustekinumab in a 15‐year‐old girl , 2020, The British journal of dermatology.

[14]  C. Bodemer,et al.  Management of congenital ichthyoses: European guidelines of care, part one , 2018, The British journal of dermatology.

[15]  D. Metze,et al.  Infliximab therapy for Netherton syndrome: A case report , 2017, JAAD case reports.

[16]  A. Yalcin.  A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels , 2016, Immunopharmacology and immunotoxicology.

[17]  A. Cianferoni,et al.  The importance of TSLP in allergic disease and its role as a potential therapeutic target , 2014, Expert review of clinical immunology.

[18]  I. Maatouk,et al.  Narrowband ultraviolet B phototherapy associated with improvement in Netherton syndrome , 2012, Clinical and experimental dermatology.

[19]  J. Saurat,et al.  Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a reduction of thymic stromal lymphopoietin levels in the skin. , 2011, The Journal of investigative dermatology.